| 000 | 01767 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512201949.0 | ||
| 264 | 0 | _c19831217 | |
| 008 | 198312s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00254250 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStraus, D J | |
| 245 | 0 | 0 |
_aCombination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1983 |
||
| 300 |
_a80-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLomustine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMechlorethamine _xadministration & dosage |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 650 | 0 | 4 | _aVindesine |
| 700 | 1 | _aMyers, J | |
| 700 | 1 | _aKoziner, B | |
| 700 | 1 | _aLee, B J | |
| 700 | 1 | _aClarkson, B D | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 11 _gno. 2 _gp. 80-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00254250 _zAvailable from publisher's website |
| 999 |
_c6194956 _d6194956 |
||